Wegovy Pill vs Injection: Price Comparison (2026)
Updated April 20, 2026
For years, Wegovy meant one thing: a weekly injection. That changed in December 2025 when Novo Nordisk launched an oral version of Wegovy — same active ingredient (semaglutide), same brand name, taken as a pill. Now anyone shopping for Wegovy has to choose between two formulations with different prices, different convenience profiles, and slightly different insurance coverage.
If you're deciding between the two in 2026, the short answer is that the pill is cheaper at the starting dose and the injection has broader insurance coverage. Here's the full breakdown.
Two Forms, Two Price Structures
The retail prices look almost identical — $1,350/mo for the injection, $1,349/mo for the pill — which is Novo Nordisk's usual approach. Almost nobody pays retail, though. The self-pay programs are where the two formulations start to diverge.
Wegovy Injection (Available Since 2021)
- TrumpRx: $199/month flat at all doses
- NovoCare self-pay: $349/month
- GoodRx: $199 introductory pricing, then typically $349+
- Savings card (with commercial insurance): $25/month
Wegovy Pill (Launched December 2025)
- TrumpRx: $149/month flat at all doses
- NovoCare self-pay: $149/month starting dose, $299/month maintenance
- Savings card (with commercial insurance): $25/month
Side-by-Side Price Comparison
| Source | Injection | Pill | Difference |
|---|---|---|---|
| Retail | $1,350 | $1,349 | $1 |
| TrumpRx (all doses) | $199 | $149 | $50/mo |
| NovoCare (starting) | $349 | $149 | $200/mo |
| NovoCare (maintenance) | $349 | $299 | $50/mo |
| Savings card (covered) | $25 | $25 | tie |
At every self-pay tier the pill is cheaper, with the gap ranging from $50/mo (TrumpRx) to as much as $200/mo (NovoCare starting dose).
Insurance Coverage: Injection Still Wins Here
The injection has been on formularies since 2021 and has a track record. Roughly 60–70% of commercial plans now cover it for chronic weight management, though most require prior authorization.
The pill is too new for most insurers to have formally adjudicated. Coverage decisions typically lag FDA approval by 6–12 months, so expect significant improvement through the second half of 2026. For now, if you're counting on insurance to cover Wegovy, the injection is the safer bet — the pill may be rejected as "non-formulary" until your plan catches up.
Compare GLP-1 Prices Now
See real prices from telehealth providers and direct-to-consumer programs — updated regularly.
View Price Comparison →The Convenience Trade-Off
Price isn't the only factor. The two forms have genuinely different daily experiences.
Injection: Once a week, sub-cutaneous injection with a pre-filled pen. Most people can do it themselves in under a minute. No food timing. Missing a weekly dose is tolerable — you can still take it up to 5 days late.
Pill: Once a day, oral. Here's the catch: Wegovy pill must be taken on an empty stomach with no more than 4 oz of water, and you can't eat or drink anything else for at least 30 minutes. For many people this ends up being a first-thing-in-the-morning ritual. Miss that 30-minute window and the drug's absorption drops dramatically.
If you already have a consistent morning routine, the pill fits easily. If you don't, or if you travel a lot, the weekly injection is often more practical despite being less squeamish-friendly.
A Third Alternative: Foundayo
If you want an oral GLP-1 without the empty-stomach ritual, Foundayo (orforglipron, Eli Lilly, approved April 2026) is the alternative worth knowing about. It's also a daily pill with starting pricing around $149/mo — same as Wegovy pill — but it doesn't have the food-timing restriction. Foundayo is a different active ingredient (orforglipron instead of semaglutide), and it's too new to have the same coverage history as Wegovy, but if the food ritual is your dealbreaker it's worth asking your doctor about.
Which Is Cheaper Long-Term?
The pill wins on sticker price. At TrumpRx's flat $149/month vs. $199/month for the injection, you save roughly $600 per year on the medication alone. That gap holds across doses.
The injection wins on insurance leverage. If your plan covers the injection at a $25 copay and rejects the pill, the injection's effective cost is far lower.
So the decision framework is simple:
- Paying cash: Pill is cheaper — TrumpRx $149/mo is the floor.
- Covered by commercial insurance: Call your plan, check both formulations, go with the one at $25/mo. Likely the injection for now.
- Government insurance (Medicare/Medicaid): Savings cards don't apply. TrumpRx or NovoCare self-pay, pill is cheaper.
Ready to find your cheapest option?
Your lowest price depends on your state, insurance, and condition — and it may not even be Wegovy. Our comparison tool checks every GLP-1 side by side.
→ Use Our Free Comparison Tool